Analytics (Former Employee), Mississauga, ON – November 24, 2015
Pros: Good pay. Comparable benefits to other healthcare companies.
Cons: Job security. Medical device business is not growing. Profit is slim.
Recent restructuring occurred in the fall of 2015 with almost 10% reduction in headcount. No job security. Low morale. The company has lost/spin off its hemo business. What's left with Baxter now is not as quite profitable as the hemo business. Therefore, future profit is cloudy and fierce competition from the medical device industry as a whole.